Particle.news

Download on the App Store

Brunkow, Ramsdell and Sakaguchi Win 2025 Nobel in Medicine for Immune Tolerance Breakthroughs

The laureates defined how self‑tolerance is enforced by regulatory T cells under FOXP3 control, enabling therapies now in clinical testing.

Overview

  • The Nobel Assembly at the Karolinska Institute named Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi co‑recipients for discoveries concerning peripheral immune tolerance.
  • Shimon Sakaguchi identified regulatory T cells in 1995, revealing a peripheral mechanism that restrains harmful immune responses outside the thymus.
  • In 2001, Mary E. Brunkow and Fred Ramsdell pinpointed FOXP3 as essential to Treg function and linked its mutations to scurfy mice and the human autoimmune disorder IPEX.
  • Follow‑up work in 2003 demonstrated that FOXP3 programs the development of regulatory T cells, unifying the cellular and genetic insights.
  • The prize totals 11 million Swedish kronor to be shared equally, and the committee highlighted Treg‑based approaches now in clinical trials for autoimmune disease, cancer and transplantation.